V-GO DISPOSABLE INSULIN DELIVERY DEVICE V-GO 20

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,consumer report with the FDA on 2014-03-21 for V-GO DISPOSABLE INSULIN DELIVERY DEVICE V-GO 20 manufactured by Valeritas, Llc.

Event Text Entries

[4267882] Type 2 diabetic female pt per physician has been on v-go 20 1-2 weeks. The pt reports she had a blood glucose of 11 mg/dl on (b)(6) 2014 about 9:30am. The pt reports she had just fixed her breakfast, was walking to the parlor and passed out. Her husband found her on the floor and called the rescue squad. The rescue squad removed the v-go. She was treated and hospitalized. In the hospital she indicated she had high blood glucose of 248, 300, and 209 mg/dl. The pt reported she did not use the clicks (mealtime bolus) while using the v-go. She indicated she changed the v-go every day at 8am. When asked if she saw insulin left in the v-go when she removed it she reported there was no insulin left. She reported she had blood glucose of 30, 35, 40, 57, and 63 mg/dl while using the vgo and her symptom was shakiness. The pt indicated she had reported these blood glucose readings to her health care provider. The pt also reported her blood glucose was also 1999 and 300mg/dl while using the v-go. The pt indicated she was checking her blood glucose 4x day and the blood glucose could be any level any time; there was no pattern. The pt indicated there was no differences in lifestyle except she was gaining weight. She reported treating the low blood glucose with orange juice. She reported she ate normally the day before the blood glucose of 11 mg/dl. She reported she often does not take bedtime snack but if she does it is peanut butter and crackers. The pt reported she does not know her aic. The pt reports pre-vgo she was taking 20 units of lantas twice a day and novolog of 10 units twice a day. She indicated she took the same oral medications pre-vgo and when using the vgo of 15mg of actos in the am, glipizide 10mg twice a day and metformin 500 mg twice a day. Pre-vgo the pt reports her blood glucose range was 200-500mg/dl. She reported the lowest blood glucose she ever had pre-vgo was 82mg/dl without symptoms.
Patient Sequence No: 1, Text Type: D, B5


[11619438] Procedure requires filing an mdr based on the following info: pt had blood glucose reading level of 11mg/dl. Pt passed out and was unable to recognize and treat the event without third party intervention. Pt was hospitalized. Device was not available for investigation so no contributory cause could be identified for the low blood glucose reading.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1226572-2014-00004
MDR Report Key3697644
Report Source04,CONSUMER
Date Received2014-03-21
Date of Report2014-02-28
Date of Event2014-02-28
Date Mfgr Received2014-02-28
Date Added to Maude2014-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSCOTT HUIE
Manufacturer Street750 ROUTE 202S SUITE 600
Manufacturer CityBRIDGEWATER NJ 08807
Manufacturer CountryUS
Manufacturer Postal08807
Manufacturer Phone908927920
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameV-GO DISPOSABLE INSULIN DELIVERY DEVICE
Generic NameV-GO
Product CodeKZE
Date Received2014-03-21
Model NumberV-GO 20
Lot NumberUNK
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerVALERITAS, LLC
Manufacturer Address750 ROUTE 202 S STE 100 BRIDGEWATER NJ 088072597 US 088072597


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2014-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.